Stay updated on ABP 654 for Psoriasis: Moderate-Severe Clinical Trial
Sign up to get notified when there's something new on the ABP 654 for Psoriasis: Moderate-Severe Clinical Trial page.

Latest updates to the ABP 654 for Psoriasis: Moderate-Severe Clinical Trial page
- Check6 days agoChange DetectedA banner announces an NIH website transition and says federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI).SummaryDifference1%

- Check13 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check20 days agoChange DetectedThe footer revision marker changed from v3.7.0 to v3.7.1, while the page remains a 403 error screen.SummaryDifference0.2%

- Check41 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study details, indicating the study record is currently inaccessible on the site.SummaryDifference19%

- Check62 days agoChange DetectedThe page now shows Revision: v3.6.6, indicating a new version of the study page; this typically reflects a minor update or maintenance without changing the substantive study information.SummaryDifference0.0%

- Check84 days agoChange DetectedPage revision updated to v3.6.5 from v3.6.4. This is a routine version update and does not modify the study details or user-facing content.SummaryDifference0.0%

Stay in the know with updates to ABP 654 for Psoriasis: Moderate-Severe Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABP 654 for Psoriasis: Moderate-Severe Clinical Trial page.